SCHRODER INVESTMENT MANAGEMENT GROUP - SUPERNUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$999,860
+2.4%
1,000,0000.0%0.00%
-50.0%
Q4 2022$976,574
+0.7%
1,000,0000.0%0.00%0.0%
Q3 2022$970,000
-0.1%
1,000,0000.0%0.00%
+100.0%
Q2 2022$971,000
-1.5%
1,000,0000.0%0.00%0.0%
Q1 2022$986,0001,000,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 71,162$69,799,0004.72%
ZAZOVE ASSOCIATES LLC 27,692,000$27,021,0002.38%
ADVENT CAPITAL MANAGEMENT /DE/ 61,727,000$60,252,0001.17%
SHENKMAN CAPITAL MANAGEMENT INC 7,637,000$7,524,0000.85%
NN Investment Partners Holdings N.V. 38,700,000$37,743,0000.30%
CAMDEN ASSET MANAGEMENT L P /CA 5,825,000$5,684,0000.18%
EDMOND DE ROTHSCHILD HOLDING S.A. 4,479,000$4,384,0000.16%
Lombard Odier Asset Management (Europe) Ltd 2,005,000$1,905,0000.16%
PRUDENTIAL PLC 41,809,000$40,973,0000.12%
Calamos Advisors LLC 22,303,000$21,829,0000.12%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders